Slashdot Mirror


After FDA Objections, 23andMe Won't Offer Health Information

sciencehabit writes "The company 23andMe will no longer provide health information to people who purchase its DNA testing kit, it announced last night.The change was 'to comply with the U.S. Food and Drug Administration's directive to discontinue new consumer access during our regulatory review process,' the statement said. While current customers will still have access to a 23andMe online database noting the health issues associated with their particular DNA, the company will not update that information, and customers who purchased its Personal Genome Service (PGS) on or after 22 November will receive only information about their ancestry and their raw genetic data without interpretation." It would be great to see a secondary market in this kind of analysis emerge.

26 of 146 comments (clear)

  1. There already is a secondary market already by PapayaSF · · Score: 4, Informative

    From snpedia.com:

    The easiest way to make a report is to visit promethease.com. This takes about 10 minutes and costs $5. [...] Promethease is a tool to build a personal DNA report based on SNPedia and a person's genotype (DNA) data. Customers of DNA testing services (23andMe, FamilyTreeDNA, Ancestry.com, Complete Genomics, ...) can use it to learn more about themselves completely independently of whichever company produced their data.

    --
    Q: What does the "B." in Benoit B. Mandelbrot stand for? A: Benoit B. Mandelbrot
  2. good riddance by ljw1004 · · Score: 4, Interesting

    Good.

    My family all had our genomes sequenced by 23andMe. The only area we have expertise in is Alzheimers, and (1) their Alzheimers explanations were misleading, (2) they made it REALLY hard to learn the raw data about what they found in our genomes, i.e. which SNPs they tested and what they found: instead they only boiled it down into a useless "you have 20% chance of getting Alzheimers" which was scientifically incorrect, lacked confidence levels, lacked context.

    I would love to get the raw data from their results, and I'd love to have someone better than them provide the tools to analyze & understand it.

    1. Re:good riddance by PCM2 · · Score: 5, Insightful

      Perhaps this is why the FDA put the kabosh on it

      The FDA was very clear about why they stopped it. It wasn't necessarily that the information was misleading, but that it would lead patients to make decisions about their own care without necessarily consulting a doctor, which the FDA thinks is not a good idea -- and I totally see their point, frankly.

      For example, one of the things that 23andMe can tell you is how well you might respond to one drug versus another, because of your specific genetic makeup. If you take that advice and change the dosage of your medication or switch to a different medication without discussing the issue with your doctor, you could cause yourself serious harm.

      On the far end of the scale, "false positives" for some diseases could be catastrophic -- say, if a woman was erroneously told she had a high chance of contracting a certain type of breast cancer and decided to have a double mastectomy, like Angelina Jolie had done.

      23andMe claimed that all it was doing was giving people information. But really, the way the information was structured and presented to the customer made it clear that it was designed to be diagnostically relevant and that they should use it to make decisions about how to proceed with health care. Any service that performs that function clearly falls under the jurisdiction of the FDA, IMHO.

      --
      Breakfast served all day!
    2. Re:good riddance by E++99 · · Score: 2

      The FDA was very clear about why they stopped it. It wasn't necessarily that the information was misleading, but that it would lead patients to make decisions about their own care without necessarily consulting a doctor, which the FDA thinks is not a good idea -- and I totally see their point, frankly.

      For example, one of the things that 23andMe can tell you is how well you might respond to one drug versus another, because of your specific genetic makeup. If you take that advice and change the dosage of your medication or switch to a different medication without discussing the issue with your doctor, you could cause yourself serious harm.

      How could that possibly be within any legitimate government's domain? Using the same rational they could shut down wikipedia or rxlist. Clearly, people DO make medical decisions for themselves based on wikipedia and rxlist without talking to a doctor. The idea that some people believe it is the responsibility of the government to stop that sort of thing is terrifying to me. I should have autonomy over my own body, and the government should not stand in the way of me obtaining information for making my own rational decisions about how to exercise that autonomy.

    3. Re:good riddance by PCM2 · · Score: 3, Insightful

      How could that possibly be within any legitimate government's domain? Using the same rational they could shut down wikipedia or rxlist.

      They sure would shut down Wikipedia or RXList if those services allowed you to make an appointment to consult them for medical advice. Even campus health nurses have to be licensed.

      What Wikipedia offers now is pretty much the same thing as reading information out of a book. You can't stop people from doing that, and there's no law against it.

      What 23andMe does is market a product that you use to extract unique information about your own body, which is then presented to you in the form of suggestions about what health measures you should take -- in other words, medical advice. Very different.

      --
      Breakfast served all day!
    4. Re:good riddance by E++99 · · Score: 4, Informative

      What 23andMe does is market a product that you use to extract unique information about your own body, which is then presented to you in the form of suggestions about what health measures you should take -- in other words, medical advice. Very different.

      Whoa, what? They have never been in the business of medical advice! What they did is to say, "you have genetic marker X which according to studies A and B are indicative of a 20% increased susceptibility to disease Y or and 50% increased likelihood to have an adverse reaction to drug Z." That is not medical advice! That is mere information, filtered by your genetic markers.

    5. Re:good riddance by biohazard123 · · Score: 2

      I would love to get the raw data from their results, and I'd love to have someone better than them provide the tools to analyze & understand it.

      Go to the dropdown link where your name is at top of left of the page. Click browse raw data, then click download...............

    6. Re:good riddance by tlambert · · Score: 4, Insightful

      The FDA was very clear about why they stopped it. It wasn't necessarily that the information was misleading, but that it would lead patients to make decisions about their own care without necessarily consulting a doctor, which the FDA thinks is not a good idea -- and I totally see their point, frankly.

      The FDA made them stop because doctors dislike being cut out of the loop, and insurance companies like being cut out of the loop even less than the doctors, and they would prefer to have you get the data through a disclosure mechanism which gives your insurance company better actuarial information. "Having a Dr. explain the information to the patients one on one" is just a place to hang that hat.

      For example, one of the things that 23andMe can tell you is how well you might respond to one drug versus another, because of your specific genetic makeup. If you take that advice and change the dosage of your medication or switch to a different medication without discussing the issue with your doctor, you could cause yourself serious harm.

      Yeah, in case you wondered, people can not self prescribe non-over the counter medications. So that excuse doesn't fly, either, since your doctor will be involved in writing the script for the new medication, and your insurance company will be paying for it, and like mine did, probably try to give you a cheaper generic version of a similar drug in place of the one your doctor actually wrote the script for, and then called it "equivalent". I've had that pulled on me, and been given "generic allergy medication" containing a cornstarch binder in place of the other one - when corn products were why I taking the damn stuff in the first place.

    7. Re:good riddance by Mashdar · · Score: 4, Insightful

      Does anyone else find it upsetting that the local CVS is packed with whole aisles of homeopathic "remedies" with no proven efficacy (or worse, disproven), but some company can't tell you what your genes might mean? Apparently the FDA is about protecting what goes in your eyes than what goes in you mouth?

    8. Re:good riddance by electroniceric · · Score: 2

      The FDA made them stop because doctors dislike being cut out of the loop, and insurance companies like being cut out of the loop even less than the doctors, and they would prefer to have you get the data through a disclosure mechanism which gives your insurance company better actuarial information.

      This sounds like one of those ads at the bottom of blogs "New service that doctors hate!!1". Seriously though, do you have any evidence for these claims?

      The FDA asked a 23andMe a simple question - show us the evidence that when you say that a person has an elevated risk of say, death, that that claim is true. Then they talked 23andMe 14 times over a couple years, then waited 11 months with no reply. Then they made them stop making those claims. So where is that the ravening hordes of doctors and insurers fit in there?

      Now imagine that 23andMe said the person was at low risk of death (like from heart disease) and that turned out to be ahem... mildly inaccurate. Was that the part the doctors hate?

      Notes that if 23andMe sticks to providing raw data, they are not making medical claims. Ravening hordes begone!

  3. Re:smart by Albanach · · Score: 3, Informative

    There is a secondary market. Most large hospitals have genetic counselors who are trained and qualified to interpret and present the results of genetic testing.

  4. Re:smart by farble1670 · · Score: 2

    if it was that simple, wouldn't 23andMe have just hired some of these people? it might cost them, but probably cheaper than losing their entire business. how useful is it to the average person to gut a bunch of raw genetic data dumped on them?

  5. Re:smart by pepty · · Score: 4, Informative

    Those are the results of individual FDA approved genetic tests.

    A "secondary market" for running thousands of tests at once would run into the same problem that 23andMe did: if you are going to sell diagnostic services in the USA then you will need to get FDA approval. The options are to only provide raw data and let someone else generate the report for free (see Promethease, mentioned below) or move the whole company someplace where law enforcement won't bother it. I could see 23andMe spinning off an independent foundation that would generate free reports, thus allowing their core business (building up a database of peoples DNA and personal/family medical histories that they can rent out for medical research free from the normal regulatory hurdles) to proceed unhindered. They would just have to be very careful to make certain there was no linkage between the for profit and the free companies: the non-profit would have to generate reports from data of any source, not just SNPs from 23andMe, it couldn't share any board members or employees with 23andMe, Google, etc.

    Next legal challenge for 23andMe: doing medical research on people (gathering their DNA and medical histories, analyzing, allowing 3rd parties to analyze, etc) without getting IRB approvals first.

  6. Too bad it's taken down... by sldunn · · Score: 3, Interesting
    As long as people understand that the results are only based on research/papers, 23andme is really awesome. It's best to discuss things with your doctor, and get things double checked, rather than to treat 23andme as some alternate to proper healthcare and checkups.

    I mean, really, who the hell would spit into a tube, pay $100 bucks and start a potentially harmful treatment regimen without seeing a doctor?

    Speaking from experience, 23andme did identify that one of her genes leaves her susceptible to having bad side effects of one of the medications she was taking (and she was suffering from this side effect). Taking the 23andme health report to her doctor let her move onto an alternate treatment, which is working *much* better.

    I hope that a revisited health report/traits thing comes back soon. Or maybe put it behind a test wall, and make sure people to understand exactly what they are getting.

  7. Re:smart by ColdWetDog · · Score: 2

    The problem is that 23andme was trying to make it 'that simple' and beyond. Their recent literature downplayed the (difficult) part about relative risk, probabilities and how to analyze the data in a rationale way and played up the 'we can make you live longer' aspect. Taking the information to a qualified genetic counselor would be the best way to evaluate the subject for the vast majority of people. But that is time consuming, expensive and you have to really think about stuff.

    Not a very good way to make money these days. The FDA put a kabosh to that.

    --
    Faster! Faster! Faster would be better!
  8. Re:smart by ceoyoyo · · Score: 2

    The problem is, if a random person gets a genetic test done their report is along the lines of "such and such a variant has been associated with a 0.000000028% chance of developing such and such", etc. That's not very sexy marketing.

  9. The science is open.. by xtal · · Score: 3, Insightful

    Just need to link the science (published) and the genotype. It's all open.

    Next up is banning people from sequencing their own genomes without a MD.

    The real story here is who's the loser - it's not you; your DNA is your DNA, and the sequences are there or they aren't. The insurance industry are the ones who are actually worried about these tests - all of a sudden you have data they don't, and they can't apply their actuarial models anymore. Hilarity ensures.

    May we all live in interesting times.

    --
    ..don't panic
  10. From a 2010 Cell paper by sat1308 · · Score: 5, Informative

    One company, for example, offers 166 tests in one of its testing packages where approximately 60% of the tests (99) are categorized as âpreliminary researchâ(TM) because the genetic-association data have not yet been replicated (www.23andme.com/health/all/). These tests are given 1, 2, or 3 stars based on the size of the study that supports the genetic association for which they test. Information for each of these tests cites references for the original ïnding of the genetic association, including the journal where it was published and the study size. It also provides the number of attempted replications and the number of contrary studies that have been published. Although transparent, examination of the scientiïc evidence provided for many of the genetic associations in this category raises the question of whether these tests should even be included in a genetic-testing package. Two of the ïve genetic tests with 1-star status (those for âavoidance of errorâ(TM) and âobsessive compulsive disorderâ(TM)) are based on single studies with fewer than 100 participants (https://www.23andme.com/you/health/). In both cases the variants map to the D2 dopamine receptor, a gene that has repeatedly been associated with human behavioral traits and attracted newspaper headlines, only to have the associations refuted in later studies [8]. Eight of the 37 (22%) available 2-star-rated genetic associations (originating from a single study with less than 750 participants) have a âcontrary studyâ(TM) indicated. Two different 3-star tests, one for Lou Gehrigâ(TM)s Disease (ALS) and another for obesity, utilize variants that have been positively associated with disease in one or two studies, respectively. However, both these variants have failed replication in four additional studies (https://www.23andme.com/you/health/). Although, the company boasts of its 'systematic vetting processâ(TM) used to determine which research ïndings to include in its genetic-testing package, a number of highly questionable tests continue to be offered to consumers.

    http://www.ncbi.nlm.nih.gov/pubmed/20828856

  11. Re:smart by Belial6 · · Score: 2

    I don't know if I would go that far. U.C. Davis does genetic testing for pregnant women, and I got the joy of talking to one when my wife was pregnant. The 'Genetic Counselor' had no idea what the data meant. Every question I asked was met with a blank stare and the repeating of the line from the script she was given. It was awfully similar to calling an Indian tech support line.

  12. 23andMe is just plain bogus by quixote9 · · Score: 2

    They can't do analysis, a secondary market can't do it, nobody can. The science just isn't there yet to draw useful conclusions for an individual on the basis of DNA in isolation.

    Note that: in isolation. That's what 23and Me was peddling. Hospitals and genetic counselors and doctors are doing something else. They have the whole medical history. They have, or should have, enough training to understand population genetics, statistics, and where somebody's DNA data fits in to all that. (Although a comment lower down this thread talks about a blank-brained counselor. They happen. Run, do not walk, out of their offices.)

    So, no, it would not be "great to see a secondary market in this kind of analysis emerge." It would be just as bogus as 23andMe, given our current state of knowledge.

    1. Re:23andMe is just plain bogus by Anonymous Coward · · Score: 3, Insightful

      What's your definition of "useful conclusion"? Because I'm pretty sure it's different than what 23andMe was peddling and what all of us satisfied customers expected. Most 23andMe reports are equivocal on their face, in a good way. Some, like markers for Parkinson's or Alzheimer's, are also pretty clear. They tell you in plain English that the lack of a marker does not mean you're free from risk. If a marker is present, they give you a risk factor. But in no way did they diagnose you with Parkinson's.

      Everybody thinks that they're smarter than most other people, and people like you just assume that most other people can't comprehend this stuff. Well, 1) we can and 2) it doesn't matter because 23andMe reports are of a different type entirely than what a professional genetic counselor would possess.

      Show me one person who was duped by 23andMe? Even my own mother, who is quite naive about science-related topics, consumed her reports with a grain of salt, and without needing any warnings from me. Everybody understood that 23andMe is to professional genetic counseling as Walgreens is to The Mayo Clinic. In other words, professional and trustworthy in so far as a commercial vendor can be, but not in the same league as a real healthcare provider.

      In an age where people obsess over stuff like HFCS and juice fasts, 23andMe cut through all the crap with hard data and reports which, despite all the inherent limitations, were damn interesting, if not in the rare case positively life changing. People understood the limitations, even the science-deficient anti-HFCS and organics crowd.

      What the FDA did was pounce on some lofty marketing language. Big whip. The FDA just wants to shutdown the commoditization of genetic counseling, period. And it's ultimately going to cost all of us a ton of money.

  13. Thord party analysis by n6kuy · · Score: 4, Informative

    > It would be great to see a secondary market
    > in this kind of analysis emerge.

    There are already companies (livewello.com, for instance) that will take your 23andme raw data and analyze it for certain traits and risk factors.

    --
    If you disagree with me on social issues, then it's pretty clear that you are a narrow-minded bigot.
  14. Re:smart by nitehawk214 · · Score: 2

    The problem is that 23andme was trying to make it 'that simple' and beyond. Their recent literature downplayed the (difficult) part about relative risk, probabilities and how to analyze the data in a rationale way and played up the 'we can make you live longer' aspect. Taking the information to a qualified genetic counselor would be the best way to evaluate the subject for the vast majority of people. But that is time consuming, expensive and you have to really think about stuff.

    Not a very good way to make money these days. The FDA put a kabosh to that.

    How did they plan on making people live longer if they did not have anyone analyze the results? Or was their entire business plan to get people to pay top dollar for information they cannot understand?

    --
    I'm a good cook. I'm a fantastic eater. - Steven Brust
  15. Re:smart by JWSmythe · · Score: 4, Informative

    That quote isn't quite complete. They've only discontinued new user access to health related tests. They're still providing ancestry information.

    The majority of the really useful information is genetic. The health information was secondary. Really, the whole health thing was vague at best, and it didn't take a rocket scientist to figure it out.

    For example, gallstones. My risk is 6.2%, where avg risk is 7.0%. Not bad, I have a lower chance.

    I had to have my gallbladder removed a year ago, because I had two golf ball size stones. Yup, anything greater than a 0.0% chance means there is a chance. Lucky me.

    Anyways, here's the full email they just sent out to 23andMe customers today.

    Dear 23andMe Customers,

    I'm writing to update you on our conversation with the U.S. Food and Drug Administration and how it impacts you.

    If you are a customer whose kit was purchased before November 22, 2013, your 23andMe experience will not change. You will be able to access both ancestry and health-related information as you always have.

    23andMe has complied with the FDA's directive and stopped offering new consumers access to health-related genetic results while the company moves forward with the agency's regulatory review processes. Be sure to refer to our 23andMe blog for updates.

    We stand behind the data we have generated for customers. Our lab partner adheres to strict quality standards that are part of the Clinical Laboratory Improvement Amendments of 1988 - known as CLIA. These are the same standards used in the majority of other health and disease-related tests.

    You are among the first people in the world to ever get access to their genomes. You are genetic pioneers. Thank you for your ongoing support and we look forward to continuing to serve you.

    Anne Wojcicki
    Co-founder and CEO, 23andMe

    --
    Serious? Seriousness is well above my pay grade.
  16. Re:The FDA's mission to save idiots from themselve by Lawrence_Bird · · Score: 2

    Let me go rah rah for you. If 23andme is so shitty at providing accurate medical information to aid the lay person in evaluating their results then the MARKET will put them out of business as consumers will a) stop using them and b) competitors who provide better service will emerge.

    There is no need for government intervention here. Please go control your own person and family and leave the rest of us the fuck alone.

  17. Herbal supplements have congresscritters. by Behrooz · · Score: 2

    Sen. Orrin Hatch (R-UT) would like to speak with you about how your health can enjoy the benefits of herbal supplements!

    --
    "We have to go forth and crush every world view that doesn't believe in tolerance and free speech." - David Brin